Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK; Corvinus University of Budapest, Budapest, Hungary.
Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Lancet Healthy Longev. 2023 Aug;4(8):e386-e398. doi: 10.1016/S2666-7568(23)00086-7. Epub 2023 Jul 10.
Hip fracture care delivery varies between hospitals, which might explain variations in patient outcomes and health costs. The aim of this study was to identify hospital-level organisational factors associated with long-term patient outcomes and costs after hip fracture.
REDUCE was a record-linkage cohort study in which national databases for all patients aged 60 years and older who sustained a hip fracture in England and Wales were linked with hospital metrics from 18 organisational data sources. Multilevel models identified organisational factors associated with the case-mix adjusted primary outcomes: cumulative all-cause mortality, days spent in hospital, and inpatient costs over 365 days after hip fracture.
Between April 1, 2016, and March 31, 2019, 178 757 patients with an index hip fracture were identified from 172 hospitals in England and Wales. 126 278 (70·6%) were female, 52 479 (29·4%) were male, and median age was 84 years (IQR 77-89) in England and 83 years (77-89) in Wales. 365 days after hip fracture, 50 354 (28·2%) patients had died. Patients spent a median 21 days (IQR 11-41) in hospital, incurring costs of £14 642 (95% CI 14 600-14 683) per patient, ranging from £10 867 (SD 5880) to £23 188 (17 223) between hospitals. 11 organisational factors were independently associated with mortality, 24 with number of days in hospital, and 25 with inpatient costs. Having all patients assessed by an orthogeriatrician within 72 h of admission was associated with a mean cost saving of £529 (95% CI 148-910) per patient and a lower 365-day mortality (odds ratio 0·85 [95% CI 0·76-0·94]). Consultant orthogeriatrician attendance at clinical governance meetings was associated with cost savings of £356 (95% CI 188-525) and 1·47 fewer days (95% CI 0·89-2·05) in the hospital in the 365 days after hip fracture per patient. The provision of physiotherapy to patients on weekends was associated with a cost saving of £676 (95% CI 67-1285) per patient and with 2·32 fewer days (0·35-4·29) in hospital in the 365 days after hip fracture.
Multiple, potentially modifiable hospital-level organisational factors associated with important clinical outcomes and inpatient costs were identified that should inform initiatives to improve the effectiveness and efficiency of hip fracture services.
Versus Arthritis.
髋部骨折的护理在不同医院之间存在差异,这可能解释了患者结局和医疗费用的差异。本研究的目的是确定与髋部骨折后长期患者结局和成本相关的医院层面的组织因素。
REDCUE 是一项基于记录的队列研究,将英格兰和威尔士所有年龄在 60 岁及以上、发生髋部骨折的患者的国家数据库与来自 18 个组织数据源的医院指标进行了链接。多水平模型确定了与病例组合调整的主要结局相关的组织因素:累计全因死亡率、住院天数和髋部骨折后 365 天的住院费用。
2016 年 4 月 1 日至 2019 年 3 月 31 日,从英格兰和威尔士的 172 家医院中确定了 178757 名索引髋部骨折患者。126278 名(70.6%)为女性,52479 名(29.4%)为男性,中位年龄为英格兰 84 岁(IQR 77-89),威尔士 83 岁(77-89)。髋部骨折后 365 天,50354 名(28.2%)患者死亡。患者的中位住院天数为 21 天(IQR 11-41),每位患者的住院费用为 14642 英镑(95%CI 14600-14683),医院之间的费用范围为 10867 英镑(SD 5880)至 23188 英镑(17223)。11 个组织因素与死亡率独立相关,24 个因素与住院天数相关,25 个因素与住院费用相关。在入院后 72 小时内让所有患者接受骨科老年病医生评估与每位患者节省 529 英镑(95%CI 148-910)和降低 365 天死亡率(比值比 0.85 [95%CI 0.76-0.94])相关。在髋部骨折后 365 天内,每位患者的骨科老年病医生参加临床治理会议的次数与节省 356 英镑(95%CI 188-525)和减少 1.47 天(95%CI 0.89-2.05)的住院天数相关。为周末的患者提供物理治疗与每位患者节省 676 英镑(95%CI 67-1285)和髋部骨折后 365 天内减少 2.32 天(0.35-4.29)的住院天数相关。
确定了多个潜在可改变的与重要临床结局和住院费用相关的医院层面的组织因素,这应有助于制定改善髋部骨折服务效果和效率的计划。
关节炎协会。